Compounds > tyrosine

tyrosine and MEA 2b

tyrosine has been researched along with MEA 2b in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (33.33)18.2507
2000's6 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bongarzone, I; Cassinelli, G; Cremona, M; Cuccuru, G; Gorla, L; Lanzi, C; Miccichè, F; Mondellini, P; Pierotti, MA1
Chung, HK; Hwang, ES; Hwang, JH; Jung, HS; Kim, DW; Kim, JM; Park, KC; Park, SH; Park, YJ; Shong, M; Song, JH; Suh, JM; Yun, HJ1
Bongarzone, I; Cantù, M; Gorla, L; Miccichè, F; Mondellini, P; Patelli, C; Pierotti, MA1
Asai, N; Iwashita, T; Matsuyama, M; Murakami, H; Takahashi, M1
Asai, N; Iwashita, T; Murakami, H; Takahashi, M1
Asai, N; Ito, S; Iwashita, T; Murakami, H; Takahashi, M1
Futami, H; Ichihara, M; Iwashita, T; Kawai, K; Kurokawa, K; Miyauchi, A; Murakami, H; Qiao, S; Takahashi, M1
Fenzi, G; Fusco, A; Melillo, RM; Monaco, C; Salvatore, D; Santoro, M; Vecchio, G; Visconti, R1
Kawai, K; Kurokawa, K; Murakami, H; Shimono, Y; Takahashi, M; Yamamura, Y1

Other Studies

9 other study(ies) available for tyrosine and MEA 2b

ArticleYear
Proteomics study of medullary thyroid carcinomas expressing RET germ-line mutations: identification of new signaling elements.
    Molecular carcinogenesis, 2009, Volume: 48, Issue:3

    Topics: Animals; Antineoplastic Agents; Carcinoma, Medullary; Epidermal Growth Factor; ErbB Receptors; Female; Gefitinib; Germ-Line Mutation; Humans; Mice; Mice, Nude; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Oncogene Proteins; Phosphorylation; Proteomics; Proto-Oncogene Proteins c-ret; Quinazolines; Signal Transduction; Thyroid Neoplasms; Tyrosine

2009
Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases.
    Molecular endocrinology (Baltimore, Md.), 2004, Volume: 18, Issue:11

    Topics: Carcinoma, Papillary; DNA-Binding Proteins; Genes, MHC Class II; HLA-DR Antigens; Humans; Interferon Regulatory Factor-1; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Nuclear Proteins; Oncogene Proteins; Oncogene Proteins, Fusion; Phosphoproteins; Phosphorylation; Promoter Regions, Genetic; Protein Inhibitors of Activated STAT; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; RNA, Messenger; Signal Transduction; Small Ubiquitin-Related Modifier Proteins; STAT1 Transcription Factor; Thyroid Neoplasms; Trans-Activators; Transcriptional Activation; Tyrosine

2004
RET oncoproteins induce tyrosine phosphorylation changes of proteins involved in RNA metabolism.
    Cellular signalling, 2006, Volume: 18, Issue:12

    Topics: Adaptor Proteins, Signal Transducing; Alternative Splicing; Animals; Biological Transport; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Nucleus; Cytoplasm; DNA-Binding Proteins; Electrophoresis, Polyacrylamide Gel; Humans; Immunoprecipitation; Mice; Models, Biological; Multiple Endocrine Neoplasia Type 2b; NIH 3T3 Cells; Phosphorylation; Protein Isoforms; Proteins; Proto-Oncogene Proteins c-ret; RNA; RNA-Binding Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Thyroid Gland; Transfection; Tyrosine

2006
Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN2A or MEN2B mutation.
    Oncogene, 1996, Feb-01, Volume: 12, Issue:3

    Topics: 3T3 Cells; Animals; Blotting, Western; Cell Transformation, Neoplastic; Codon; Drosophila Proteins; Humans; Mice; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Mutagenesis, Site-Directed; Point Mutation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Recombinant Proteins; Transfection; Tyrosine

1996
A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with shc adaptor proteins.
    The Journal of biological chemistry, 1996, Jul-26, Volume: 271, Issue:30

    Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Amino Acid Sequence; Animals; Cell Transformation, Neoplastic; Drosophila Proteins; Humans; Mice; Molecular Sequence Data; Multiple Endocrine Neoplasia; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Mutation; Proteins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Tyrosine

1996
Molecular mechanisms of development of multiple endocrine neoplasia 2 by RET mutations.
    Journal of internal medicine, 1998, Volume: 243, Issue:6

    Topics: Carcinoma, Medullary; Drosophila Proteins; Hirschsprung Disease; Humans; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Mutation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms; Tyrosine

1998
A two-hit model for development of multiple endocrine neoplasia type 2B by RET mutations.
    Biochemical and biophysical research communications, 2000, Feb-24, Volume: 268, Issue:3

    Topics: 3T3 Cells; Adult; Amino Acid Substitution; Animals; Drosophila Proteins; Female; Germ-Line Mutation; Humans; Male; Mice; Models, Genetic; Multiple Endocrine Neoplasia Type 2b; Mutation, Missense; Pedigree; Protein Structure, Tertiary; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Transformation, Genetic; Tyrosine

2000
Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B.
    Cancer research, 2001, Feb-15, Volume: 61, Issue:4

    Topics: 3T3 Cells; Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Animals; COS Cells; Drosophila Proteins; Enzyme Activation; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; PC12 Cells; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-ret; ras Proteins; Rats; Receptor Protein-Tyrosine Kinases; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Thyroid Neoplasms; Tyrosine

2001
Role of Dok1 in cell signaling mediated by RET tyrosine kinase.
    The Journal of biological chemistry, 2002, Sep-06, Volume: 277, Issue:36

    Topics: 3T3 Cells; Adaptor Proteins, Signal Transducing; Animals; Cell Line; DNA-Binding Proteins; Drosophila Proteins; Enzyme Activation; Glutathione Transferase; Immunoblotting; Mice; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Models, Biological; Multiple Endocrine Neoplasia Type 2b; Mutation; Oncogene Proteins; Phenylalanine; Phosphoproteins; Phosphorylation; Plasmids; Precipitin Tests; Protein Binding; Protein Structure, Tertiary; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; ras GTPase-Activating Proteins; ras Proteins; Receptor Protein-Tyrosine Kinases; RNA-Binding Proteins; Signal Transduction; Two-Hybrid System Techniques; Tyrosine

2002